The global market for Complicated Skin and Skin Structure Infections (cSSSI) drugs is currently navigating a period of rapid evolution, driven by the dual pressures of rising infection rates and the critical need for novel antibiotics to combat antimicrobial resistance (AMR). As we move through 2025, the market is characterized by significant R&D investment and a shift toward more spe... https://www.databridgemarketresearch.com/reports/global-complicated-skin-and-skin-structure-infections-csssi-drugs-market